Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Louisiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Louisiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Louisiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Charles Lyon (NPI 1558380303)

Field	Value
Entity Type	Individual
Organization	Charles Lyon
Address	836 Olive St
City	Shreveport
State	LA
ZIP	71104
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 19, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider is essentially a Medicare-focused retina specialist: lifetime Medicare revenue is $2.6M and there is no Medicaid billing on file, indicating an effectively single-payer footprint with Medicare representing the entirety of documented public-payer volume. The lack of Medicaid claims suggests limited or no participation in state Medicaid networks and a business largely driven by Medicare-covered retina services.

Revenue is highly concentrated: the precomputed top three Medicare codes account for 84.9% of this provider's total Medicare revenue, indicating that a small set of services drives the vast majority of reported Medicare income. That concentration raises sensitivity to shifts in drug pricing, reimbursement, or utilization patterns for those specific codes.

The clinical and operational profile is dominated by intravitreal pharmacologic therapy and high-volume outpatient management. J0178 appears as the single largest revenue driver with 2.5K claims, $689 avg paid/claim, and $1.7M revenue (66.3% of Medicare revenue); 67028 appears with 1.9K claims, $79 avg paid/claim, and $152.8K revenue (5.9%); and 92134 (retinal imaging) shows 4.1K claims, $28 avg paid/claim, and $113.6K revenue (4.4%), together reflecting a mix of high-cost anti‑VEGF drug administration, intravitreal procedures, and routine retinal diagnostics.

Office evaluation-and-management services are an outsized component of billed activity relative to national peers: 99214 accounts for 3.9K claims, $85 avg paid/claim, and $332.5K revenue (12.8% of Medicare revenue) and ranks #83 of 479517 (100th percentile; extreme outlier, far above typical national volume). Similarly, 92134 ranks #124 of 26868 (100th percentile; extreme outlier), reinforcing that this provider reports exceptionally high volumes of E/M and retinal imaging compared with national benchmarks.

Despite the dominant revenue share from J0178, the provider’s national standing for that specific drug is not an extreme volume outlier: J0178 ranks #322 of 3204 providers nationally (90th percentile; typical, unremarkable volume). This pattern implies that the large revenue contribution from J0178 is driven primarily by the high per‑claim payment ($689 avg paid/claim and $1.7M total) rather than an extraordinarily unusual claim count relative to peers.

The practice also bills a mix of newer agents and biosimilars alongside established medications, suggesting therapeutic diversity in intravitreal treatments. Examples include J2777 (faricimab) with 4K claims and $110.9K revenue (4.3%) at a lower national rank (17th percentile; typical, unremarkable volume), Q5124 (ranibizumab biosimilar) with 285 claims and $46.2K revenue (1.8%), and J9035 (bevacizumab) with 501 claims and $27.6K revenue (1.1%), indicating use of both branded high-cost agents and lower-cost alternatives.

From a competitive-stance perspective, the provider is a major national outlier on several ambulatory codes (99214, 99204, 92134) while being a more typical participant for high-revenue drug administration codes like J0178 and 67028 (both listed as typical, unremarkable volume at the 90th percentile for J0178 and 67028). This mix suggests the provider operates a high-throughput retinal clinic that is unusually busy for office visits and retinal imaging but not uniquely high in injection volumes compared with the broader specialty.

The provider has a long tenure in the NPI registry (NPI enumerated 2006-07-19, ~20 years ago), which, combined with $2.6M in lifetime Medicare revenue, points to an established practice in Shreveport, LA with sustained Medicare activity concentrated in retina services. That longevity plus the concentrated revenue mix suggests a stable, specialized operation but one that would be materially affected by changes in reimbursement or utilization for its few top codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,500	$690	$1.7M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	3,910	$90	$332.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,930	$80	$152.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,060	$30	$113.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	3,960	$30	$110.9K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	440	$110	$48.7K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	290	$160	$46.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	270	$110	$31.1K
J9035	Injection, bevacizumab, 10 mg	500	$60	$27.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	70	$60	$4.3K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Louisiana Distribution

Charles Lyon — 5 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Louisiana

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	50	300	$680	$371.5K
J2777	20	30	6,660	$30	$309.4K
Q5124	2	10	760	$160	$123.1K
J2781	4	10	830	$120	$86K
67028	1	70	410	$80	$44.3K
99214	1	6,670	110	$80	$16.5K
J9035	3	40	130	$50	$10.8K
67228	13	10	30	$250	$8.2K
99213	2,921	6,060	70	$50	$8.1K
92134	3	360	70	$20	$7.4K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Charles Lyon, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
James Keane	AR	Procedural Dermatology Physician	$4.9M	$0
Harshivinderjit Bains	TX	Ophthalmology Physician	$4.1M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Amar Patel	TX	Ophthalmology Physician	$3.8M	$0
Thomas Bochow	TX	Ophthalmology Physician	$3.6M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
Jyothi Mallepalli	LA	Rheumatology Physician	$3.2M	$0
Kirtan Koticha	LA	Hematology & Oncology Physician	$3.1M	$0
Rochelle Robicheaux Metoyer	LA	Rheumatology Physician	$2.9M	$0
Jonathan Tzu	TX	Ophthalmology Physician	$2.8M	$0

Nearby Providers

Other providers in the same ZIP code as Charles Lyon, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
St. Matthew's Direct Care Service	LA	Home Health Agency	$0	$26.9M
Council On Alcoholism And Drug Abuse Of Northwest Louisiana	LA	Substance Abuse Rehabilitation Facility	$0	$24.9M
Behavioral Specialists Of La	LA	Clinical Psychologist	$0	$18.7M
Superior Counseling Services, LLC	LA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$9.2M
St. Matthew's Direct Care Service	LA	Home Health Agency	$0	$9.1M
Choices Coordinated Care Solutions, Inc.	LA	Case Management Agency	$0	$8.2M
Riley Physical Therapy, Inc	LA	Physical Therapist	$0	$8.1M
Quality Support Coordination Inc	LA	Case Management Agency	$0	$7.3M
Community Health Care Solutions, LLC.	LA	Community/Behavioral Health Agency	$0	$6.8M
In Home Respiratory, LLC	LA	Durable Medical Equipment & Medical Supplies	$0	$6.7M

Charles Lyon — Billing Profile & Reimbursement Data

Sign up for Charles Lyon — Billing Profile & Reimbursement Data policy alerts

Charles Lyon — Billing Profile & Reimbursement Data

Sign up for Charles Lyon — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References